Atrial Cardiomyopathy in Valvular Heart Disease: From Molecular Biology to Clinical Perspectives.
Molnár AÁ, Sánta A, Pásztor DT, Merkely B.
Cells. 2023 Jul 6;12(13):1796. doi: 10.3390/cells12131796.
Diabetic Cardiomyopathy.
Dillmann WH.
Circ Res. 2019 Apr 12;124(8):1160-1162. doi: 10.1161/CIRCRESAHA.118.314665.
Valvular heart disease and cardiomyopathy: reappraisal of their interplay.
Ajmone Marsan N, Graziani F, Meucci MC, Wu HW, Lillo R, Bax JJ, Burzotta F, Massetti M, Jukema JW, Crea F.
Nat Rev Cardiol. 2024 Jan;21(1):37-50. doi: 10.1038/s41569-023-00911-0. Epub 2023 Aug 10.
Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
Nakamura K, Miyoshi T, Yoshida M, Akagi S, Saito Y, Ejiri K, Matsuo N, Ichikawa K, Iwasaki K, Naito T, Namba Y, Yoshida M, Sugiyama H, Ito H.
Int J Mol Sci. 2022 Mar 25;23(7):3587. doi: 10.3390/ijms23073587.
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.
Meyers DE, Basha HI, Koenig MK.
Tex Heart Inst J. 2013;40(4):385-94.
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.
Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, Daubert JP, de Chillou C, DePasquale EC, Desai MY, Estes NAM 3rd, Hua W, Indik JH, Ingles J, James CA, John RM, Judge DP, Keegan R, Krahn AD, Link MS, Marcus FI, McLeod CJ, Mestroni L, Priori SG, Saffitz JE, Sanatani S, Shimizu W, van Tintelen JP, Wilde AAM, Zareba W.
Heart Rhythm. 2019 Nov;16(11):e301-e372. doi: 10.1016/j.hrthm.2019.05.007. Epub 2019 May 9.
Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M, Li Y, Li S, Lv J.
Front Endocrinol (Lausanne). 2022 Apr 7;13:851941. doi: 10.3389/fendo.2022.851941. eCollection 2022.
Valvular heart disease: shifting the focus to the myocardium.
Ajmone Marsan N, Delgado V, Shah DJ, Pellikka P, Bax JJ, Treibel T, Cavalcante JL.
Eur Heart J. 2023 Jan 1;44(1):28-40. doi: 10.1093/eurheartj/ehac504.
Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.
Peng ML, Fu Y, Wu CW, Zhang Y, Ren H, Zhou SS.
Front Endocrinol (Lausanne). 2022 Jun 15;13:907757. doi: 10.3389/fendo.2022.907757. eCollection 2022.
Management of high risk cardiac conditions in pregnancy: Anticoagulation, severe stenotic valvular disease and cardiomyopathy.
Lau E, DeFaria Yeh D.
Trends Cardiovasc Med. 2019 Apr;29(3):155-161. doi: 10.1016/j.tcm.2018.07.009. Epub 2018 Jul 22.
